Accordingly, the effects of insulin-containing dermal patches on the expression of insulin-stimulated enzymes and facilitative glucose transporters in insulin responsiveness target tissues, most importantly, Navitoclax 923564-51-6 muscle and liver of STZ-induced diabetic rats were also assessed. The current study investigated whether transdermal application of pectin hydrogel insulin matrix patches of different insulin concentrations sustain controlled release of insulin into the bloodstream of streptozotocin -induced diabetic rats and alleviate a variety of diabetic symptoms. The results show that topical application of pectin insulin-containing dermal patches to STZ-induced diabetic rats increases plasma insulin concentration, reduces blood glucose and increases liver and muscle glycogen levels as well as the expression of GS and GLUT4 in hepatic and skeletal muscle tissues, respectively. The findings are of considerable importance because application of insulin-containing dermal patches would not only free diabetic patients from some daily bolus injections needed to maintain a constant insulin concentration, but also provide pain-free self-administration of insulin for patients and probably improve compliance. STZ at dose used selective-ly destroys or impairs secretion of insulin from b cells of the pancreas and the systemic changes which occur following this are related to the induced diabetic state. Indeed, untreated STZ-diabetic rats exhibited significantly low plasma insulin concentration and increased plasma glucose concentrations compared to non-diabetic rats perhaps due to destruction of pancreatic b-cells. PI hydrogel matrix patches evoked changes in blood glucose and plasma insulin concentrations comparable to positive control experiments using sc insulin. The doses of insulin in pectin dermal patches compare with those previously used in human studies. Successful transdermal delivery of insulin was also corroborated with the observation of extensive expression of insulin receptor substrates in the skin of STZ-induced rats following application of insulin-containing dermal patches. The insulin receptor, a transmembrane glycoprotein present in virtually all vertebrate tissues undergoes tyrosyl autophosphorylation in response to insulin binding to the extracellular a-subunit. Conceivably, insulin released from insulin-containing dermal patches enhanced the tyrosine kinase activity of the receptor towards the expression of IRS in the skin of STZ-induced rats and in insulin target tissues such as skeletal muscle and the liver. The key to strict glycaemic control with exogenous insulin lies with delivery methods that maintain physiological insulin concentrations. Therefore, the pectin insulin-containing dermal patches delivered physiologically relevant amounts of pharmacologically active insulin. A PI hydrogel matrix patch formulation will be easy to use and will not require elaborative devices to prevent drug leakage as in solution formulations. Pectin has been used as a carrier of a wide variety of biologically active agents, for sustained release applications and targeting drugs to the colon for either local treatment or systemic action.